Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Emcure launches India first generic version of sucroferric oxyhydroxide for chronic kidney disease patients

expresspharmaJuly 02, 2020

Tag: Emcure , Dynulta , CKD

PharmaSources Customer Service